Literature DB >> 21217127

Molecular characterization of fluoroquinolone resistance in Haemophilus parasuis isolated from pigs in South China.

Lili Guo1, Jianmin Zhang, Chenggang Xu, Yongda Zhao, Tao Ren, Bin Zhang, Huiying Fan, Ming Liao.   

Abstract

OBJECTIVES: To perform molecular characterization of fluoroquinolone-resistant Haemophilus parasuis isolated from South China.
METHODS: H. parasuis isolates were investigated for quinolone and fluoroquinolone susceptibility and screened for plasmid-mediated quinolone resistance (PMQR) determinants by PCR amplification and DNA sequence analysis. Additionally, quinolone resistance-determining region (QRDR) mutations of DNA gyrase (gyrA and gyrB) and topoisomerase IV (parC and parE) were determined. The genetic relatedness among the strains was analysed by PFGE.
RESULTS: These H. parasuis isolates showed higher MIC values of nalidixic acid, enrofloxacin, ciprofloxacin, levofloxacin, norfloxacin and lomefloxacin. Moreover, qnrA1, qnrB6 and aac(6')-Ib-cr were present in 2.61%, 0.87% and 2.61% of the 115 isolates, respectively. One strain possessed both aac(6')-Ib-cr and qnrA1. Mutation analysis of QRDRs showed that the resistant strains carried at least one mutation in gyrA (at codon 83 or 87), but no mutation was detected in gyrB. PFGE analysis showed great genetic diversity among these resistant H. parasuis strains.
CONCLUSIONS: The data presented here highlight the presence of qnr and aac(6')-Ib-cr genes in H. parasuis strains from South China. Moreover, the gyrA (at codon 83 or 87) mutation is linked to fluoroquinolone resistance in H. parasuis. Transferable PMQR determinants and multiple target gene mutations play important roles in the fluoroquinolone resistance of H. parasuis. These data provide important insights into the mechanism of fluoroquinolone resistance in H. parasuis, thereby highlighting the usefulness of fluoroquinolones for the treatment and control of this infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21217127     DOI: 10.1093/jac/dkq497

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

Review 1.  SOS response and its regulation on the fluoroquinolone resistance.

Authors:  Ting-Ting Qin; Hai-Quan Kang; Ping Ma; Peng-Peng Li; Lin-Yan Huang; Bing Gu
Journal:  Ann Transl Med       Date:  2015-12

Review 2.  Plasmid-mediated quinolone resistance.

Authors:  George A Jacoby; Jacob Strahilevitz; David C Hooper
Journal:  Microbiol Spectr       Date:  2014-10

3.  Prevalence and characterization of genotypic diversity of Haemophilus parasuis isolates from southern China.

Authors:  Jianmin Zhang; Chenggang Xu; Lili Guo; Haiyan Shen; Xiaoling Deng; Changwen Ke; Bixia Ke; Bin Zhang; Ang Li; Tao Ren; Ming Liao
Journal:  Can J Vet Res       Date:  2012-07       Impact factor: 1.310

4.  Comparison of Haemophilus parasuis reference strains and field isolates by using random amplified polymorphic DNA and protein profiles.

Authors:  Emilie S Zehr; Dennis V Lavrov; Louisa B Tabatabai
Journal:  BMC Microbiol       Date:  2012-06-15       Impact factor: 3.605

5.  Characterization of antimicrobial resistance genes in Haemophilus parasuis isolated from pigs in China.

Authors:  Yongda Zhao; Lili Guo; Jie Li; Xianhui Huang; Binghu Fang
Journal:  PeerJ       Date:  2018-04-09       Impact factor: 2.984

6.  Comparison of PK/PD Targets and Cutoff Values for Danofloxacin Against Pasteurella multocida and Haemophilus parasuis in Piglets.

Authors:  Yu-Feng Zhou; Zhen Sun; Rui-Ling Wang; Jian-Guo Li; Chao-Yan Niu; Xian-An Li; Yun-Yun Feng; Jian Sun; Ya-Hong Liu; Xiao-Ping Liao
Journal:  Front Vet Sci       Date:  2022-02-02

7.  The Epidemiologic and Pharmacodynamic Cutoff Values of Tilmicosin against Haemophilus parasuis.

Authors:  Peng Zhang; Haihong Hao; Jun Li; Ijaz Ahmad; Guyue Cheng; Dongmei Chen; Yanfei Tao; Lingli Huang; Yulian Wang; Menghong Dai; Zhenli Liu; Zonghui Yuan
Journal:  Front Microbiol       Date:  2016-03-22       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.